Rubicon Research is an IP led Contract Development and Manufacturing Organisation (CDMO) and specialty pharmaceutical company that leverages proprietary drug delivery technologies, specialized formulation development skills, and project delivery experience to serve patients worldwide. The company focuses on developing high-quality pharmaceutical products across multiple dosage forms, including oral solids, oral liquids, sterile injectables, and drug-device combinations. Rubicon Research supplies products to various markets, including the USA, EU, Australia, New Zealand, Canada, Turkey, and Korea, and is actively seeking partners in emerging markets.

Services include:
– Finished Dosage Forms
– Pharmaceutical Product Development
– Manufacturing of Oral Solids
– Manufacturing of Oral Liquids
– Manufacturing of Sterile Injectables
– Development of Drug-Device Combinations

Rubicon Research is committed to innovation and excellence in the pharmaceutical industry, continuously enhancing its portfolio to better serve global markets. For more information, please visit rubicon.co.in.